Understanding Andrographis
Andrographis paniculata (“king of bitters”) is an herb native to South and Southeast Asia whose leaves and aerial parts are rich in diterpene lactones—primarily andrographolide, with related compounds (deoxy-/neo-/14-deoxy-11,12-didehydroandrographolide). Modern supplements standardize these actives because they drive the plant’s anti-inflammatory and immunomodulatory effects. In cell and animal models, andrographolide dampens NF-κB signaling and downstream cytokines, supports balanced innate immune activity, and shows antiviral and antibacterial actions. Clinically, extracts are used for acute upper respiratory tract infections (URTI)—the common cold, sore throat, uncomplicated sinusitis—and for short-term immune support during seasonal illness.
You’ll encounter several preparations:
Standardized leaf extracts (often 10–30% andrographolides), sometimes branded (e.g., AP-Bio®/KalmCold®).
Combination formulas pairing Andrographis with adaptogens such as Eleutherococcus (e.g., Kan Jang®).
Tinctures/teas of dried aerial parts—traditional but highly variable in potency and bitterness.
Diet alone cannot provide meaningful amounts of andrographolide; the compound is not a dietary nutrient, and culinary use is minimal. Standardized extracts provide consistent, trial-like dosing and are therefore preferred when you want reliable effects on URTI symptom burden and duration.
Mechanistically, three pathways matter most for real-world use:
Inflammation modulation — downshifts NF-κB and COX-2 activity, easing throat pain and inflammatory nasal symptoms.
Antiviral/antimicrobial support — laboratory evidence suggests interference with viral replication and bacterial quorum signaling, aligning with clinical reductions in symptom severity.
Immune tone — promotes a “right-sized” response (neither overstimulated nor sluggish), which is helpful early in self-limited viral colds.
Key Benefits
Relieves common-cold symptoms and shortens illness. Standardized Andrographis extracts reduce sore throat, cough, and nasal symptoms and can shave days off recovery versus placebo in acute URTI trials.
Eases sore throat discomfort. Anti-inflammatory activity in mucosal tissue translates to lower throat-pain scores and quicker return to normal swallowing in several randomized studies.
Supports immune resilience in high-exposure seasons. Short courses at the first sign of a cold help the immune system resolve symptoms faster without sedating side effects common to some OTCs.
Reality check: Evidence is strongest for short-term URTI relief. Data for chronic immune conditions or long-COVID are preliminary—stick to acute, time-limited use unless directed by a clinician.
Research Findings
URTI (common cold), standardized extract: 5–7-day, randomized, double-blind trial in 223 adults with uncomplicated URTI gave KalmCold® (Andrographis extract) 200 mg/day vs placebo; total symptom scores fell sooner and farther in the extract group, with separation from placebo emerging by days 3–5 and good tolerability.
Mild COVID-19, fixed combo (Kan Jang®): 14-day, quadruple-blind, randomized, placebo-controlled trial in 140 adults used Kan Jang® (Andrographis + Eleutherococcus; ~90 mg/day andrographolides) adjunct to standard care; the treatment reduced clinical deterioration, shortened recovery time, and lowered symptom severity on validated URTI scales versus placebo. :contentReference[oaicite:0]{index=0}
Early-intervention URTI (combo extract): Randomized, double-blind studies of Kan Jang® during the first 36–48 hours of symptoms report faster relief of sore throat, cough, and nasal discharge and fewer sick-leave days than placebo, supporting prompt, short-course use when a cold begins.
Best Sources & Dosage
Where it comes from
Leaf/aerial-part extracts standardized to andrographolides (check label for % and mg/day).
Branded extracts (e.g., AP-Bio®/KalmCold®) used in URTI trials.
Combination formulas (e.g., Kan Jang®) pairing Andrographis with Eleutherococcus; evidence relates to the combo, not Andrographis alone.
Evidence-based adult ranges
At first sign of a cold (mono-extract): 300–600 mg/day of a standardized extract (providing ~60–120 mg/day andrographolides) in divided doses for 5–10 days.
Combination formulas: follow labeled directions; trial protocols commonly supplied ~90 mg/day andrographolides total for 10–14 days alongside standard supportive care.
Prevention during high-exposure weeks: some practitioners use low daily doses (e.g., 150–300 mg extract) for up to 2–4 weeks, though prevention data are less robust than treatment data.
Timing & tips
Start within 24–48 hours of symptom onset for best odds of benefit.
Take with meals to reduce stomach upset; very bitter tablets can be swallowed quickly or taken in capsules.
Consider pairing with saline nasal irrigation, adequate fluids, and rest; avoid duplicate actives across multi-ingredient “cold” products.
Safety, interactions & who should avoid it
Generally well tolerated in trials up to 14 weeks; common effects are GI upset, headache, and bitter/metallic taste. Rare allergic reactions (including anaphylaxis) have been reported—stop and seek care if rash, wheeze, or facial swelling occur.
Possible additive effects with anticoagulants/antiplatelets (platelet-aggregation signals in preclinical work); use caution if on warfarin, DOACs, or high-dose NSAIDs.
May lower blood pressure or blood sugar modestly; monitor if you take antihypertensives or glucose-lowering drugs.
Autoimmune conditions: immunomodulatory herbs can be unpredictable—discuss with your specialist.
Pregnancy/lactation: avoid due to insufficient safety data and concerning animal fertility signals.
Children: many products are adult-dosed; choose pediatric formulations and consult a clinician.
Label literacy
- Look for standardization (e.g., “20–30% andrographolides”) and a daily milligram amount of andrographolides, not just total herb weight.
- Single-herb products make it easier to match trial dosing; if using combinations, ensure each active is transparently listed.
Dosage Quick-Reference
Acute URTI (mono-extract): 300–600 mg/day standardized extract (≈60–120 mg andrographolides) • 5–10 days • Outcome: symptom severity & duration ↓.
Acute URTI (combo, Kan Jang®): per label to supply ~90 mg/day andrographolides • 10–14 days • Outcome: deterioration risk & sick days ↓. :contentReference[oaicite:1]{index=1}
Seasonal support (short stints): 150–300 mg/day extract • 2–4 weeks • Outcome: preventive evidence limited; use for brief high-exposure windows.
Safety note: Do not continue long-term without breaks; avoid in pregnancy/lactation and stop if allergic symptoms occur.